New epigenetic drug strategy to treat cancer
Researchers have discovered that inhibiting CDK9, a DNA transcription regulator, reactivates genes that have been epigenetically silenced by cancer. Reactivation leads to restored tumor suppressor gene expression and enhanced anti-cancer immunity.
from Latest Science News -- ScienceDaily https://ift.tt/2ArQfEi
from Latest Science News -- ScienceDaily https://ift.tt/2ArQfEi
Comments
Post a Comment